Stocks · Health care · Pharmaceutical Preparations

OMEROS CORP

OMER Clue Score25

United States Fiscal year ends December CIK 0001285819 Results filed 12 Aug 2026

Add to watchlist

What the insiders did Mostly scheduled

By person

10 insiders · 70 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Gregory A MD Demopulos

Chairman, CEO & President

$25.20K (1)

$10.39M (13) scheduled

−$10.36M

1,769,308

2.44%

$37.07M

+33.4%

Marcia S. Kelbon

VP Patent and General Counsel

—

$3.36M (7) scheduled

−$3.36M

210,645

0.2910%

$4.41M

+26.4%

Michael A Jacobsen

VP, Finance & CAO

—

$2.04M (11) scheduled

−$2.04M

14,000

0.0193%

$293.30K

—

David J. Borges

VP, Finance & CAO

—

$1.46M (7) scheduled

−$1.46M

0

0.0000%

$0.00

−100.0%

Peter B Cancelmo

VP, General Counsel

—

$929.67K (2) scheduled

−$929.67K

200

0.0003%

$4.19K

0.0%

Thomas J. Cable

Director

—

$853.16K (9) scheduled

−$853.16K

35,067

0.0484%

$734.65K

−23.9%

Arnold C Hanish

Director

—

$314.39K (4) scheduled

−$314.39K

22,400

0.0309%

$469.28K

+80.6%

Peter A MD Demopulos

Director

$15.30K (1)

—

+$15.30K

372,898

0.5151%

$7.81M

+6.7%

Leroy E. MD PhD Hood

Director

—

—

—

74,390

0.1028%

$1.56M

+36.8%

Thomas F. Bumol

Director

—

—

—

10,000

0.0138%

$209.50K

—